In Treatment of Allergic conditions A Rest 5mg/500mg/20mg Tablet provides relief from symptoms such as blocked or runny nose, sneezing, and itchy or watery eyes. This will make it easier for you to go about your daily activities. It can also give relief from allergic reactions after insect bites and symptoms of hives and eczema such as rash, swelling, itching, and irritation. This will improve the appearance of your skin and you may find that your mood and self-confidence improve as well. It rarely has any serious side effects and you may only need to take it on days you have symptoms. If you are taking it to prevent getting symptoms you should use it regularly to get the most benefit.
It is unsafe to consume alcohol with A Rest 5mg/500mg/20mg Tablet.
Information regarding the use of A Rest 5mg/500mg/20mg Tablet during pregnancy is not available. Please consult your doctor.
A Rest 5mg/500mg/20mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
A Rest 5mg/500mg/20mg Tablet does not usually affect your ability to drive.
A Rest 5mg/500mg/20mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of A Rest 5mg/500mg/20mg Tablet may be needed. Please consult your doctor. Use of A Rest 5mg/500mg/20mg Tablet is not recommended in patients with severe kidney disease.
A Rest 5mg/500mg/20mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of A Rest 5mg/500mg/20mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of A Rest 5mg/500mg/20mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More